---
title: 'Independent Tissue-Based Biomarkers in Endometrioid Endometrial Cancer: Tumor
  Budding in Microsatellite Instability and WHO Grading in Copy-Number-Low Patients'
date: '2023-08-12'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37568650/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20230812180946&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: The molecular characterization of endometrial endometrioid adenocarcinomas
  has provided major advances in its prognostic stratification. However, risk assessment
  of microsatellite instability (MSI) and copy-number (CN)-low cases remains a challenge.
  Thus, we aimed to identify tissue-based morphologic biomarkers that might help in
  the prognostic stratification of these cases. Histomorphologic parameters (WHO grading,
  tumor budding (TB), tumor-stroma ratio (as a quantitative description of ...
disable_comments: true
---
The molecular characterization of endometrial endometrioid adenocarcinomas has provided major advances in its prognostic stratification. However, risk assessment of microsatellite instability (MSI) and copy-number (CN)-low cases remains a challenge. Thus, we aimed to identify tissue-based morphologic biomarkers that might help in the prognostic stratification of these cases. Histomorphologic parameters (WHO grading, tumor budding (TB), tumor-stroma ratio (as a quantitative description of ...